Drug Trial Radar · NCT01241344
Phase 2 Study to Evaluate Brincidofovir for the Prevention of Adenovirus Disease
Last checked: Nov 19, 2026Latest source record: Jul 21, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
52
Actual
Start
Nov 2010
Primary completion
Jun 2013
Study completion Jun 2013
Sponsor
- Lead sponsor
- Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ)
- Sponsor type
- Industry
- First posted
- Nov 16, 2010
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 3 months, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study was designed to assess the safety and efficacy of preemptive treatment with oral brincidofovir (BCV), as compared to placebo, for the prevention of adenovirus (AdV) disease in recipients of hematopoietic stem cell transplantation (HCT) with asymptomatic AdV viremia.
Conditions
- Adenovirus Disease
Interventions
BrincidofovirDrug
* Adult subjects: 200mg BCV administered as 50mg tablets taken orally either once weekly (QW; 4 tablets) or twice weekly (BIW; 2 tablets). * Pediatric subjects: 4mg/kg BCV (not to exceed a total single dose of 200mg) administered using a 10 mg/mL liquid formulation taken orally either QW (as 4 mg/kg) or BIW (as 2 mg/kg).
PlaceboOther
Adult subjects: Matching placebo tablets taken orally either once weekly (QW; 4 tablets) or twice weekly (BIW; 2 tablets). • Pediatric subjects: Matching liquid placebo taken orally either QW (as 4 mg/kg) or BIW (as 2 mg/kg).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Clinically Significant AdV InfectionTime frame: 12 weeks
Locations
30 sites in 1 country. Site status is shown where the registry gives one.
Children's Hospital of Alabama
Birmingham, Alabama
Pheonix Children's Hospital
Phoenix, Arizona
City of Hope National Medical Center
Duarte, California
Childrens hospital of LA
Los Angeles, California
CHOC Children's Hospital
Orange, California
University of California, San Francisco
San Francisco, California
Lucile Packard Childrens hopsital at Stanford
Stanford, California
The Children's Hospital-Denver
Aurora, Colorado
Children's National Medical Center
Washington D.C., District of Columbia
Indiana University
Indianapolis, Indiana
LSU Health Sciences Center New Orleans Childrens Hospital
New Orleans, Louisiana
Harvard-Children's Hospital Boston
Boston, Massachusetts
Univeristy of Minnesota
Minneapolis, Minnesota
St. Louis Children's Hosptial
St Louis, Missouri
Hackensack University Medical Center
Hackensack, New Jersey
Memorial Sloan Kettering
New York, New York
New York Medical College
Valhalla, New York
Duke University Medical Center
Durham, North Carolina
Cincinnati Childrens Hospital
Cincinnati, Ohio
Cleveland Clinic
Cleveland, Ohio
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania
St. Judes Children's Research Hospital
Memphis, Tennessee
Vanderbilt University Medical Center
Nashville, Tennessee
UT Southwestern
Dallas, Texas
Baylor College of Medicine, Texas Childrens Hospital
Houston, Texas
MD Anderson Cancer Center
Houston, Texas
Methodist Hospital
San Antonio, Texas
Primary Children's Medical of Utah
Salt Lake City, Utah
Seattle Cancer Care Alliance
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.